Soluble ST2 is a Useful Biomarker for Grading Cerebral–Cardiac Syndrome in Patients after Acute Ischemic Stroke

This study tested whether the soluble (s)ST2 is a superb biomarker predictive of moderate to severe cerebral–cardiac syndrome (CCS) (defined as coexisting National Institute of Health Stroke Scale (NIHSS) >8 and left-ventricular ejection fraction (LVEF) <60%) in patients after acute ischemic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Pei-Hsun, Lin, Hung Sheng, Chen, Kuan-Hung, Chiang, John Y., Ko, Sheung-Fat, Shao, Pei-Lin, Chiang, Hsin-Ju, Chu, Chi-Hsiang, Li, Yi-Chen, Chai, Han-Tan, Lin, Kun-Chen, Yip, Hon-Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074380/
https://www.ncbi.nlm.nih.gov/pubmed/32054047
http://dx.doi.org/10.3390/jcm9020489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074380/
https://www.ncbi.nlm.nih.gov/pubmed/32054047
http://dx.doi.org/10.3390/jcm9020489

Ejemplares similares